Chapter 7 Bibliography - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/125847... · Journal...

Chapter 7 Bibliography

Komal Parmar, PhD Thesis

|Saurashtra University| 241

Acrysol EL 135, Product Information Sheet, Corel Pharma, India, 2013.

Acrysol K 140, Product Information Sheet, Corel Pharma, India, 2013.

Aerosil 200, Product Information Sheet, Gangwal Chemicals Ltd, India, 2013.

Agrawal AG, Kumar A, Gide PS. Self emulsifying drug delivery system for enhanced

solubility and dissolution of glipizide. Colloids and Surfaces B: Biointerfsaces, 2015;

126: 553-560.

Agrawal S, Chauhan S, Mathur R. Antifertility effects of embelin in male rats.

Andrologia, 1986; 18 (2): 125-131.

Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S. Formulation, optimization and in-

vitro–in-vivo evaluation of febuxostat nanosuspension. International Journal of

Pharmaceutics, 2015; 478: 540-552.

Akhter MH, Ahmad A, Ali J. Formulation and Development of CoQ10-Loaded S-

SNEDDS for Enhancement of Oral Bioavailability. Journal of Pharmaceutical

Innovation, 2014; 9: 121-131.

Akinlade B, Elkordy AA, Essa EA, Elhagar S. Liquisolid systems to improve the

dissolution of furosemide. Scientia Pharmaceutica, 2010; 78 (2): 325-344.

Ali HS, York P, Ali AM, Blagden N. Hydrocortisone nanosuspensions for ophthalmic

delivery: A comparative study between microfluidic nanoprecipitation and wet

milling. Journal of Controlled Release, 2011; 149 (2): 175-181.

Ambrus R, Kocbek P, Kristl J, Sibanc R, Rajko R, Szabo-Revesz P. Investigation of

preparation parameters to improve the dissolution of poorly water-soluble meloxicam.

International Journal of Pharmaceutics, 2009; 381: 153-159.

Anton N, Vandamme TF. Nano-emulsions and micro-emulsions: clarifications of the

critical differences. Pharmaceutical Research, 2011; 28(5): 978-985.

Aungst GJ. Intestinal permeation enhancers. Journal of Pharmaceutical Sciences,

2000; 89(4): 429-442.




Avachat AM, Patel VG. Self nanoemulsifying drug delivery system of stabilized

ellagic acid–phospholipid complex with improved dissolution and permeability. Saudi

Pharmaceutical Journal, 2015; 23 (3): 276-289.

Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, Talegaonkar S.

Nanoemulsion components screening and selection: A Technical Note. AAPs

PharmSciTech, 2009; 10 (1): 69-76.

Badawy MA, Kamel AO, Sammour OA. Use of biorelevant media for assessment of a

poorly soluble weakly basic drug in the form of liquisolid compacts: in-vitro and in-

vivo study. Drug Delivery, 2016; 23 (3): 818-827.

Baek IH, Kim JS, Ha ES, Choo GH, Cho W, Hwang SJ, Kim MS. Dissolution and

oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl

cellulose. International Journal of Biological Macromolecules, 2014; 67: 53-57.

Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, Kim JA, Yoo BK, Woo

JS, Yong CS, Choi HG. Enhanced oral bioavailability of dexibuprofen by a novel

solid self-emulsifying drug delivery system (SEDDS). European Journal of

Pharmaceutics and Biopharmaceutics, 2009; 72 (3): 539-545.

Bandivadekar MM, Pancholi SS, Kaul-Ghanekar R, Choudhari A, Koppikar S. Self-

microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic

surfactants: a delivery system for poorly water-soluble drug. Drug Development and

Industrial Pharmacy, 2012; 38 (7): 883-892.

Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of

ezetimibe with enhanced bioavailability potential using long chain and medium chain

triglycerides. Colloids Surface B: Biointerfaces, 2012; 100: 50-61.

Banker GS. Tablets. In: Lachman L. Liberman HA. The Theory and Practice of

Industrial Pharmacy, 3rd ed. Varghese Publishing House. 1987: 293-345.

Basa S, Muniyappan T, Karatgi P, Prabhu R, Pillai R. Production and in-vitro

characterization of solid dosage form incorporating drug nanoparticles. Drug

Development and Industrial Pharmacy, 2008; 34 (11): 1209-1218.




Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for

improvement of dissolution and oral absorption of lacidipine. I: Development and

optimization. International Journal of Pharmaceutics, 2010; 391: 203-211.

Benet LZ, Cummins CL. The drug efflux-metabolism alliance: biochemical aspects.

Advanced Drug Delivery Reviews, 2001; 50(1): S3-11.

Bhakay A, Merwade M, Bilgili E, Dave RN. Novel aspects of wet milling for the

production of microsuspensions and nanosuspensions of poorly water-soluble drugs.

Drug Development and Industrial Pharmacy, 2011; 37 (8): 963-976.

Biradar SV, Dhumal RS, Paradkar AR. Rheological investigation of self-

emulsification process: effect of co-surfactant. Journal of Pharmacy and

Pharmaceutical Sciences, 2009; 12 (2): 164-174.

Blagden N, Matas M, Gavan PT, York P. Crystal engineering of active

pharmaceutical ingredients to improve solubility and dissolution rates. Advanced

Drug Delivery Reviews, 2007; 59: 617-630.

Bolton S. Optimization techniques in pharmaceutical statistics: practical and clinical

applications. New York: Marcel Dekker, Inc.; 1997.

Borhade VB, Nair HA, Hegde DD. Development and characterization of self-

microemulsifying drug delivery system of tacrolimus for intravenous administration.

Drug Development and Industrial Pharmacy, 2009; 35: 619-630.

Bose S, Schenck D, Ghosh I, Hollywood A, Maulit E, Ruegger C. Application of

spray granulation for conversion of a nanosuspension into a dry powder form.

European Journal of Pharmaceutical Sciences, 2012; 47: 35-43.

Brahmankar DM, Jaiswal BS. Biopharmaceutics and Pharmacokinetics, A treatise. 1st

ed. Vallabh Prakashan, New Delhi, 1987.

Brij 35, Product Information Sheet, Sisco Research Lab, India, 2013.

Burra S, Yamsani M, Vobalaboina V. The liquisolid technique: an overview.

Brazilian Journal of Pharmaceutical Sciences, 2011; 47 (3): 475-482.




Cab-O-Sil® M-5, Product Information Sheet, Sigma Aldrich, India, 2013.

Capryol 90, Product Information Sheet, Gattefosse Pvt Ltd, India, 2013.

Carr RL. Evaluating flow properties of solids. Chemical Engineering, 1965; 72: 163-

168.

Cerdeira AM, Mazzotti M, Gander B. Miconazole nanosuspensions: Influence of

formulation variables on particle size reduction and physical stability. International

Journal of Pharmaceutics, 2010; 396 (1-2): 210-218.

Cerdeira AM, Werner IA, Mazzotti M, Gander B. Simultaneous quantification of

polymeric and surface active stabilizers of nanosuspensions by using near-infrared

spectroscopy. Drug Development and Industrial Pharmacy, 2012; 38(11): 1360-1370.

Cerpnjak K, Zvonar A, Vrecer F, Gasperlin M. Development of a solid self-

microemulsifying drug delivery system (SMEDDS) for solubility enhancement of

naproxen. Drug Development and Industrial Pharmacy, 2015; 41 (9): 1548-1557.

Chakraborty S, Shukla D, Mishra B, Singh S. Lipid-An emerging platform for oral

delivery of drugs with poor bioavailability. European Journal of Pharmaceutics and

Biopharmaceutics, 2009; 73:1-15.

Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in Drug Delivery: An Updated

Review. AAPS PharmSciTech, 2005; 6 (2) Article 43: E329-E357.

Chambin O, Karbowiak T, Djebili L, Jannin V, Champion D, Pourcelot Y, Cayot P.

Influence of drug polarity upon the solid-state structure and release properties of self-

emulsifying drug delivery systems in relation with water affinity. Colloids and

Surfaces B: Biointerfaces, 2009; 71(1): 73-78.

Chan HK, Kwok PC. Production methods for nanodrug particles using the bottom up

approach. Advanced Drug Delivery Reviews, 2011; 63: 406-416.

Chan LW, Lee CC, Heng PW. Ultrafine grinding using a fluidized bed opposed jet

mill effects of feed load and rotational speed of classifier wheel on particle shape.

Drug Development and Industrial Pharmacy, 2002; 28: 939-947.




Chen M, Lipid excipients and delivery systems for pharmaceutical development: A

regulatory perspective, Advanced Drug Delivery Reviews, 2008; 60: 768-777.

Chen X, Matteucci ME, Lo CY, Johnston KP, Williams RO III. Flocculation of

polymer stabilized nanocrystal suspensions to produce redispersible powders. Drug


Chhabra G, Chuttani K, Mishra AK, Pathak K. Design and development of

nanoemulsion drug delivery system of amlodipine besilate for improvement of oral

bioavailability. Drug Development and Industrial Pharmacy, 2011; 37 (8): 907-916.

Chitra M, Shyamala C, Sukumar E. Antibacterial activity of embelin. Fitoterapia,

2003; 74: 401-403.

Choi J, Yoo JY, Kwak H, Nam BU, Lee J. Role of polymeric stabilizers for drug

nanocrystal dispersions. Current Applied Physics, 2005; 5: 472-474.

Choi MJ, Briancon S, Andrieu J, Min SG, Fessi H. Effect of freeze drying process

conditions on the stability of nanoparticles. Drying Technology: An International

Journal, 2004; 22 (1-2): 335-346.

Constantinides PP, Scalart J. Formulation and physical characterization of water in oil

microemulsion containing long versus medium chain glycerides. International

Journal of Pharmaceutics, 1997; 158: 57-68.

Constantinides PP. Lipid microemulsions for improving drug dissolution and oral

absorption: physical and biopharmaceutical aspects. Pharmaceutical Research, 1995;

12(11): 1561-72.

Costa FO, Sousa JJS, Pais AACC, Formosinho SJ. Comparison of dissolution profiles

of Ibuprofen pellets. Journal of Controlled Release, 2003; 89: 199-212.

Costa P, Lobo JM. Modeling and comparison of dissolution profiles. European

Journal of Pharmaceutical Sciences, 2001; 13 (2): 123-33.

Cremophor RH 40, Product Information Sheet, BASF, India, 2013.




Crisp MT, Tucker CJ, Rogers TL, Williams III RO, Johnston KP. Turbidimetric

measurement and prediction of dissolution rates of poorly soluble drug nanocrystals.

Journal of Controlled Release, 2007; 117: 351-359.

Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G. Enhancement of oral absorption

of curcumin by self-microemulsifying drug delivery systems. International Journal of

Pharmaceutics, 2009; 371: 148-155.

Dai X, Moffat JG, Wood J, Reading M. Thermal scanning probe microscopy in the

development of pharmaceuticals. Advanced Drug Delivery Reviews, 2012; 64 (5):

449-60.

Das S, Suresh PK. Nanosuspension: a new vehicle for the improvement of the

delivery of drugs to the ocular surface. Application to amphotericin B. Nanomedicine:

Nanotechnology, Biology, and Medicine, 2011; 7: 242-247.

Date AA, Nagarsenker MS. Design and evaluation of self nanoemulsified drug

delivery systems (SNEDDS) for Cefpodoxime Proxetil. International Journal of

Pharmaceutics, 2007; 329: 166-172.

Date AA, Patravale VB. Current strategies for engineering drug nanoparticles.

Current Opinion in Colloid & Interface Science, 2004; 9: 222– 235.

Dejaegher B, Vander HY. Experimental designs and their recent advances in set up

data interpretation and analytical applications. Journal of Pharmaceutical and

Biomedical Analysis, 2011; 56: 141-158.

Deng J, Huang L, Liu F. Understanding the structure and stability of paclitaxel

nanocrystals. International Journal of Pharmaceutics, 2010; 390 (2): 242-249.

Desai PP, Date AA, Patravale VB. Overcoming poor oral bioavailability using

nanoparticle formulations – opportunities and limitations. Drug Discovery Today:

Technologies, 2012; 9(2): 87-95.

Deshmukh A, Kulkarni S. Solid self-microemulsifying drug delivery system of

ritonavir. Drug Development and Industrial Pharmacy, 2014; 40 (4): 477-487.




Detroja C, Chavhan S, Sawant K. Enhanced Antihypertensive Activity of Candesartan

Cilexetil Nanosuspension: Formulation, Characterization and Pharmacodynamic

Study. Scientia Pharmaceutica, 2011; 79 (3): 635-651.

Dhami N. Trends in Pharmacognosy: A modern science of natural medicines. Journal

of Herbal Medicine, 2013; 3(4): 123-131.

Ditner C, Bravo R, Imanidis G, Kuentz M. A systematic dilution study of self-

microemulsifying drug delivery systems in artificial intestinal fluid using dynamic

laser light backscattering. Drug Development and Industrial Pharmacy, 2009; 35 (2):

199-208.

Dixit AR, Rajput SJ, Patel SG. Preparation and bioavailability assessment of

SMEDDS containing valsartan. AAPS PharmSciTech, 2010; 11 (1): 314-321.

Dixit RP, Nagarsenker MS. Self-nanoemulsifying granules of ezetimibe: Design,

optimization and evaluation. European Journal of Pharmaceutical Sciences, 2008;

35: 183-192.

Dolenc A, Kristil J, Baumgartner S, Planinsek O. Advantages of celecoxib

nanosuspension formulation and transformation into tablets. International Journal of

Pharmaceutics, 2009; 376: 204-212.

Dressman JB, Amidon GL, Reppas C, Shah VP. Dissolution testing as a prognostic

tool for oral drug absorption: immediate release dosage forms. Pharmaceutical

Research, 1998; 15(1): 11-22.

El-Badry M, Haq N, Fetih G, Shakeel F. Solubility and dissolution enhancement of

tadalafil using self-nanoemulsifying drug delivery system. Journal of Oleo Science,

2014; 63 (6): 567-576.

Elkordy AA, Essa EA, Dhuppad S, Jammigumpula P. Liquisolid technique to enhance

and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.

International Journal of Pharmaceutics, 2012; 434 (1-2): 122-132.

Elkordy AA, Tan XN, Essa EA. Spironolactone release from liquisolid formulations

prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile




liquid vehicles. European Journal of Pharmaceutics and Biopharmaceutics, 2013; 83

(2): 203-223.

Elnaggar YSR, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery

systems of tamoxifen citrate: Design and optimization. International Journal of

Pharmaceutics, 2009; 380 (1-2): 133-141.

Emad BB, Nevine S, Shaimaa MB. SNEDDS containing bioenhancers for

improvement of dissolution and oral absorption of lacidipine. I: Development and

optimization. International Journal of Pharmaceutics, 2010; 391: 203-211.

Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through

liquisolid tablets. Formulation. In-vitro and in-vivo evaluation. European Journal of

Pharmaceutics and Biopharmaceutics, 2008; 69: 993-1003.

Fakes MG, Vakkalagadda BJ, Qian F, Desikan S, Gandhi RB, Lai C, Hsieh

A, Franchini MK, Toale H, Brown J. Enhancement of oral bioavailability of an HIV-

attachment inhibitor by nanosizing and amorphous formulation approaches.

International Journal Pharmaceutics, 2009; 370 (1-2): 167-174.

Farrokhpay S. A review of polymeric dispersant stabilisation of titania pigment.

Advances in Colloid Interface Science, 2009; 151 (1-2): 24-32.

FDA guidance for industry: Bioanalytical method validation. US Department of

Health and Human Services, Food and Drug Administration, Centre for Drug

Evaluation and Research, 2001.

Feng G, Haijun Z, Jing H, Baogang X, Fen L, Helin X, Minmin L, Chunlian X. Self

microemulsifying drug delivery system for improved oral bioavailability of

dipyridamole: preparation and evaluation. Archives of Pharmaceutical Research,

2011; 34 (7): 1113-1123.

Fricker G, Kromp T, Wendel A, Blume A, Zirkel J, Rebmann H, Setzer C, Quinket

RO, Martin F, Muller-Goymann C. Phospholipids and lipid based formulations in oral

drug delivery. Pharmaceutical Research, 2010; 27 (8): 1469-1486.




Gabrielsson J, Nyström A, Lundstedt T. Multivariate methods in developing an

evolutionary strategy for tablet formulation. Drug Development and Industrial

Pharmacy, 2000; 26 (3): 275-96.

Gadhave MV, Banerjee SK. Preparation and characterization of spherical crystals of

embelin to improve the solubility and micromeritic properties. International Journal

of Pharmaceutical and Clinical Research, 2014; 6 (4): 363-369.

Gahoi S, Jain GK, Tripathi R, Pandey SK, Anwar M, Warsi MH, Singhal M, Khar

RK, Ahmad FJ. Enhanced antimalarial activity of lumefantrine nanopowder prepared

by wet-milling DYNO MILL technique. Colloids and Surfaces B:

Biointerfaces, 2012; 95: 16-22.

Ganta S, Paxton JW, Baguley BC, Garg S. Formulation and pharmacokinetic

evaluation of an asulacrine nanocrystalline suspension for intravenous delivery.


Gao L, Zhang D, Chen M, Zheng T, Wang S. Preparation and characterization of an

oridonin nanosuspension for solubility and dissolution velocity enhancement. Drug

Development and Industrial Pharmacy, 2007; 33: 1332-1339.

Gao L, Zhang D, Chenb M, Duana C, Dai W, Jia L, Zhaoa W. Studies on

pharmacokinetics and tissue distribution of oridonin nanosuspensions. International


Gao L, Liu G, Ma J, Wang X, Zhou L, Li X. Drug nanocrystals: In-vivo

performances. Journal of Controlled Release, 2012; 160(3): 418-430.

Gao Y, Li Z, Sun M, Guo C, Yu A, Xi Y, Cui J, Lou H, Zhai G. Preparation and

characterization of intravenously injectable curcumin nanosuspension. Drug Delivery,

2011; 18 (2): 131-142.

Gao Y, Wang Y, Ma Y, Yu A, Cai F, Shao W, Zhai G. Formulation optimization and

in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. Colloids

and Surfaces B: Biointerfaces, 2009; 71: 306-314.




Garala K, Patel J, Patel A, Dharamsi A. Enhanced encapsulation of metoprolol tartrate

with carbon nanotubes as adsorbent. Applied Nanoscience, 2011; 1: 219-230.

Gelucire 44/14, Product Information Sheet, Gattefosse Pvt Ltd, India, 2013.

Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral

absorption oflipophilic drugs. European Journal of Pharmaceutics and

Biopharmaceutics, 2000; 50: 179-188.

Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for improving the

bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit

crystal growth. International Journal of Pharmaceutics, 2011; 409 (1-2): 260-268.

Ghosh MN. Fundamentals of experimental pharmacology, 3rd ed. SK Ghosh and

Others, Calcutta, India, 2008.

Ghosh PK, Murthy RSR. Microemulsions: A Potential Drug Delivery System.

Current Drug Delivery, 2006; 3: 167-180.

GIA report analysis, 2012 http://www.nutraceuticalsworld.com/contents/view_

breaking-news/2012-03-07/global-herbal-supplement-market-to-reach-107-billion-by-

2017 (Accessed on 20/02/14).

Giliyar C, Fikstad DT, Tyavanagimatt S. Challenges and opportunities in oral delivery

of poorly water-soluble drugs. Drug Delivery Technology, 2006; 6: 57-63.

Gubbi SR, Jarag R. Formulation and characterization of atorvastatin calcium

liquisolid compacts. Asian Journal of Pharmaceutical Sciences, 2010; 5 (2): 50-60.

Guo B, Zhong S, Li N, Li X, Yi J, Jin M. Dissolution enhancement of cefdinir with

hydroxypropyl-β-cyclodextrin. Drug Development and Industrial Pharmacy, 2013;

39(11): 1638-1643.

Guo Y, Wang Y, Xu L. Enhanced bioavailability of rebamipide nanocrystal tablets:

Formulation and in-vitro/in-vivo evaluation. Asian Journal of Pharmaceutical

Sciences, 2015; 10: 223-229.




Gupta R, Sharma AK, Sharma MC, Gupta RS. Antioxidant activity and protection of

pancreatic β-cells by embelin in streptozotocin-induced diabetes. Journal of Diabetes,

2012; 4: 248-256.

Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system for

adefovir dipivoxil: Design, characterization, in-vitro and ex vivo evaluation. Colloids

and Surfaces A: Physicochemical and Engineering Aspects, 2011; 392: 145-155.

Gupta S, Kesarla R, Omri A. Formulation Strategies to Improve the Bioavailability of

Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems. ISRN

Pharmaceutics, 2013; Article ID 848043.

Gursoy RN, Benita S. Self-emulsifying drug delivery systems for improved oral

delivery of lipophilic drugs. Biomedicine and Pharmacotherapy, 2004; 58:173-182.

Han S, Yao T, Zhang X, Gan L, Zhu C, Yu H, Gan Y. Lipid based formulations to

enhance oral bioavailability of the poorly water soluble drug anethol trithione: Effect

of lipid composition and formulation. International Journal of Pharmaceutics, 2009;

379: 18-24.

Harrar A, Zech O, Klaus A, Bauduin P, Kunz W. Influence of surfactant

amphiphilicity on the phase behavior of IL-based microemulsions. Journal of Colloid

and Interface Science, 2011; 362: 423–429.

Hauss DJ. Oral lipid based formulations. Advanced Drug Delivery Reviews, 2007; 59:

667-676.

Haware RV, Tho I, Bauer-Brandl A. Application of multivariate methods to

compression behavior evaluation of directly compressible materials. European

Journal of Pharmaceutics and Biopharmaceutics, 2009; 72 (1): 148-55.

He CX, He ZG, Gao JQ. Microemulsions as drug delivery systems to improve the

solubility and the bioavailability of poorly water soluble drugs. Expert Opinion on

Drug Delivery, 2010; 7: 445-460.




Hentzschel CM, Alnaief M, Smirnova I, Sakmann A, Leopold CS. Enhancement of

griseofulvin release from liquisolid compacts. European Journal of Pharmaceutics

and Biopharmaceutics, 2012; 80 (1): 130-135.

Holm R, Porter CJH, Mullertz A. Structured triglyceride vehicles for oral delivery of

halofantrine examination of intestinal lymphatic transport and bioavailability in

conscious rats. Journal of Pharmaceutical Research, 2002; 19: 1354-1361.

Horter D, Dressman JB. Influence of physicochemical properties on dissolution of

drugs in the gastrointestinal tract. Advanced Drug Delivery Reviews, 2001; 46: 75-87.

Hou C, Wang J, Le Y, Zou H, Zhao H. Preparation of azithromycin nanosuspensions

by reactive precipitation method. Drug Development and Industrial Pharmacy, 2012;

38 (7): 848-854.

https://pubchem.ncbi.nlm.nih.gov/compound/embelin (Accessed on 05/02/2013).

Huang Y, Luo X, You X, Xia Y, Song X, Yu L. The preparation and evaluation of

water-soluble SKLB610 nanosuspensions with improved bioavailability. AAPS

PharmSciTech, 2013;14 (3): 1236-1243.

Hussein A, El-Menshawe S, Afouna M. Enhancement of the in-vitro dissolution and

in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of

semisolid dispersion using Gelucire 44/14 as a carrier. Pharmazie, 2012; 67 (3): 209-

214.

ICH Harmonized tripartite guideline validation of analytical procedures: text and

methodology Q2 (R1), Parent Guideline dated October 27, 1994 (complementary

guideline on methodology dated November 6, 1996 incorporated in November 2005).

Indian Pharmacopoeia (IP); The controller of Publication: New Delhi, 2014.

Jackson CL, McKenna GB. The melting behaviour of organic materials confined in

porous solids. The Journal of Chemical Physics, 1990; 93 (12): 9002-9011.

Jakki R, Afzal Syed M, Kandadi P, Veerabrahma K. Development of a self-

microemulsifying drug delivery system of domperidone: In-vitro and in-vivo

characterization. Acta Pharmaceutica, 2013; 63 (2): 241-251.




Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and

semi-solid lipid-based formulations. Advanced Drug Delivery Reviews, 2008; 60(6):

734-746.

Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. Liquisolid technique for

dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).


Javadzadeh Y, Shariati H, Movahhed-Danesh E, Nokhodchi A. Effect of some

commercial grades of microcrystalline cellulose on flowability, compressibility and

dissolution profile of piroxicam liquisolid compacts. Drug Development and

Industrial Pharmacy, 2009; 35: 243-251.

Jia L, Wong H, Cerna C, Weitman SD. Effect of nanonization on absorption of

301029: ex vivo and in-vivo pharmacokinetic correlations determined by liquid

chromatography/mass spectrometry. Pharmaceutical Research, 2002; 19 (8): 1091-

1096.

Joshi V, Dwivedi S, Ward GH. Increase in the specific surface area of budesonide

during storage postmicronization. Pharmaceutical Research, 2002; 19 (1): 7-12.

Joy B, Lakshmi S. Antiproliferative Properties of Embelia Ribes. The Open Process

Chemistry Journal, 2010; 3: 17-22.

Jun HK, Dong HO, Yu-Kyoung O, Chul SY, Han-Gon C. Effects of solid carriers on

the crystalline properties, dissolution and bioavailability of flurbiprofen is solid self-

nanosemulsifying drug delivery system (solid SNEDDS). European Journal of


Junghanns JAH, Müller RH. Nanocrystal technology, drug delivery and clinical

applications. International Journal of Nanomedicine, 2008; 3(3): 295-310.

Junyaprasert VB, Morakul B. Nanocrystals for enhacement of oral bioavailability for

poorly water-soluble drugs. Asian Journal of Pharmaceutical Sciences, 2015; 10: 13-

23.




Kadam VD, Gattani SG. Development of colon targeted multiparticulate pulsatile

drug delivery system for treating nocturnal asthma. Drug Delivery, 2010; 17 (5): 343-

351.

Kakran M, Sahoo NG, Li L. Dissolution enhancement of quercetin through

nanofabrication, complexation, and solid dispersion. Colloids and Surfaces B:

Biointerfaces, 2011; 1: 121-130.

Kakran M, Sahoo NG, Li L, Judeh Z, Wang Y, Chong K, Loh L. Fabrication of drug

nanoparticles by evaporative precipitation of nanosuspension. International Journal

of Pharmaceutics, 2010; 383(1-2): 285-292.

Kakran M, Shegokar R, Sahoo NG, Gohla S, Li L, Müller RH. Long-term stability of

quercetin nanocrystals prepared by different methods. Journal of Pharmacy and

Pharmacology, 2012; 64 (10): 1394-1402.

Kalepu S, Manthina M, Padavala V. Oral lipid-based drug delivery systems – an

overview. Acta Pharmaceutica Sinica B, 2013; 3 (6): 361-372.

Kalhapure RS, Akamanchi KG. Oleic acid based heterolipid synthesis,

characterization and application in self-microemulsifying drug delivery system.


Kallakunta VR, Bandari S, Jukanti R, Veerareddy PR. Oral self emulsifying powder

of lercanidipine hydrochloride: Formulation and evaluation. Powder Technology,

2012; 221: 375-382.

Kamel R, Basha M. Preparation and in-vitro evaluation of rutin nanostructured

liquisolid delivery system. Bulletin of Faculty of Pharmacy, 2013; 51: 261-272.

Kang JH, Oh DH, Oh YK, Yong CS, Choi HG. Effects of solid carriers on the

crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-

nanoemulsifying drug delivery system (solid SNEDDS). European Journal of


Kang MJ, Jung SY, Song WH, Park JS, Choi SU, Oh KT, Choi HK, Choi YW, Lee

J, Lee BJ, Chi SC. Immediate release of ibuprofen from Fujicalin®-based fast-




dissolving self-emulsifying tablets. Drug Development and Industrial

Pharmacy, 2011; 37 (11): 1298-1305.

Kang MJ, Kim HS, Jeon HS, Park JH, Lee BS, Ahn BK, Moon KY, Choi YW. In situ

intestinal permeability and in-vivo absorption characteristics of olmesartan

medoxomil in self-microemulsifying drug delivery system. Drug Development and

Industrial Pharmacy, 2012a; 38 (5): 587-596.

Kaparthi S, Sathesh PR. Risperidone liquisolid compacts-Formulation and evaluation.

Der Pharmacia Sinica, 2015; 6 (6): 9-15.

Karmarkar AB, Gonjari ID, Hosmani AH, Dhabale PN. Evaluation of in-vitro

dissolution profile comparison methods of sustained release tramadol hydrochloride

liquisolid compact formulations with marketed sustained release tablets. Drug

Discoveries & Therapeutics, 2010; 4 (1): 26-32.

Karmarkar AB, Gonjari ID, Hosmani AH. Liquisolid technology for dissolution rate

enhancement or sustained release. Expert Opinion Drug Delivery, 2010a; 7 (10):

1227-1234.

Kassem MA, Abdel Rahman AA, Ghorab MM, Ahmed MB, Khalil RM.

Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.


Kaul G, Huang J, Chatlapalli R, Ghosh K, Nagi A. Quality-by-design case study:

investigation of the role of poloxamer in immediate-release tablets by experimental

design and multivariate data analysis. AAPS PharmSciTech, 2011; 12 (4): 1064-76.

Kayaert P, Van den Mooter G. Is the amorphous fraction of a dried nanosuspension

caused by milling or by drying? A case study with Naproxen and Cinnarizine.

European Journal of Pharmaceutics and Biopharmaceutics, 2012; 81 (3): 650-656.

Kesisoglou F, Panmai S, Wu Y. Nanosizing - Oral formulation development and

biopharmaceutical evaluation. Advanced Drug Delivery Reviews, 2007; 59: 631-644.

Khadka P , Ro J, Kim H, Kim I, Kim JT, Kim H, Cho JM, Yun G, Lee J.

Pharmaceutical particle technologies: An approach to improve drug solubility,




dissolution and bioavailability. Asian Journal of Pharmaceutical Sciences, 2014; 9:

304-316.

Khan A, Iqbal Z, Shah Y, Ahmad L, Ullah Z, Ullah A. Enhancement of dissolution

rate of class II drugs (Hydrochlorthiazide); a comparative study of the two novel

approaches; solid dispersion and liquid-solid techniques. Saudi Pharmaceutical

Journal, 2015; 23: 650-657.

Khanfar M, Salem MS, Hawari R. Formulation factors affecting the release of

ezetimibe from different liquisolid compacts. Pharmaceutical Development and

Technology, 2013; 18 (2): 417-427.

Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation

design and bioavailability assessment of lipidic self-emulsifying formulation of

halofantrine, International Journal of Pharmaceutics, 1998; 167: 155-164.

Kim CJ. Surface chemistry and colloids, Advanced pharmaceutics: physicochemical

principles, Boca Raton, FL: CRC Press, 2004; 193-256.

Kim DW, Kang JH, Oh DH, Yong CS, Choi HG. Development of novel flurbiprofen-

loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier.

Journal of Microencapsulation, 2012; 29(4): 323-330.

Kim GG, Poudel BK, Marasini M, Lee DW, Hiep TT, Yang KY, Kim JO, Yong CS,

Choi HG. Enhancement of oral bioavailability of fenofibrate by solid self-

microemulsifying drug delivery systems. Drug Development and Industrial

Pharmacy, 2013; 39 (9): 1431-1438.

Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan Kim S, Seo MH. In-vivo

evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. Journal

of Controlled Release, 2001; 72(1-3): 191-202.

Kimura M, Shizuki M, Miyoshi K, Sakai T, Hidaka H, Takamura H, Matoba T.

Relationship between the Molecular Structures and Emulsification Properties of

Edible Oils. Bioscience, Biotechnology, and Biochemistry, 1994; 58(7): 1258-1261.




Kohli K, Chopra S, Dhar D, Arora S, Khar RK. Self-emulsifying drug delivery

systems: an approach to enhance oral bioavailability. Drug Discovery Today, 2010;

15(21-22): 958-965.

Kommavarapu P, Maruthapillai A, Palanisamy K, Sunkara M. Preparation and

characterization of rilpivirine solid dispersions with the application of enhanced

solubility and dissolution rate. Beni-Suef University Journal of Basic and Applied

Sciences, 2015; 4(1): 71-79.

Kommuru T, Gurley B, Khan M, Reddy IK. Self-emulsifying drug delivery systems

(SEDDS) of coenzyme Q10: formulation development and bioavailability assessment.

International Journal of Pharmaceutics, 2001; 212 (2): 233-246.

Kubista M, Sjogreen B, Forootan A, Sindelka R, Jonak J, Andrade JM. Real-time

PCR gene expression profiling. European Pharmaceutical Reviews, 2007; 1: 56-60.

Kuentz M, Cavegn M. Critical concentrations in the dilution of oral self-

microemulsifying drug delivery systems. Drug Development and Industrial

Pharmacy, 2010; 36 (5): 531-538.

Kulkarni AS, Aloorkar NH, Mane MS, Gaja JB. Liquiosolid sysyem:A Review.

International Journal of Pharmaceutical Sciences and Nanotechnology, 2010; 3(1):

795-802.

Kumar P, Mittal KL (eds). Handbook of Microemulsion Science and Technology,

Marshal Dekker, New York, 1999.

Labrafil M2125 CS, Product Information Sheet, Gattefosse Pvt Ltd, India, 2013.

Labrasol, Product Information Sheet, BASF, India, 2013.

Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM. Diclofenac

nanosuspensions: influence of preparation procedure and crystal form on drug

dissolution behaviour. International Journal of Pharmaceutics, 2009; 373 (1-2): 124-

132.

Lawrence MJ, Rees GD. Microemulsion based media as novel drug delivery systems

Advanced Drug Delivery Reviews, 2000; 45: 89-121.




Leclercq SY, dos Santos RM, Macedo LB, Campos PC, Ferreira TC, de Almeida

JG, Seniuk JG, Serakides R, Silva-Cunha A, Fialho SL. Evaluation of water-in-oil-in-

water multiple emulsion and microemulsion as potential adjuvants for immunization

with rabies antigen. European Journal of Pharmaceutical Sciences, 2011; 43(5): 378-

385.

Lee J, Choi JY, Park CH. Characteristics of polymers enabling nano-comminution of

water-insoluble drugs. International Journal of Pharmaceutics, 2008; 355 (1-2): 328-

336.

Lee J. Drug nano and microparticles processed into solid dosage forms: physical

properties. Journal of Pharmaceutical Sciences, 2003; 92 (10): 2057-2068.

Lenhardt T, Vergnault G, Grenier P, Scherer D, Langguth P. Evaluation of

nanosuspensions for absorption enhancement of poorly soluble drugs: in-vitro

transport studies across intestinal epithelial monolayers. The AAPS Journal, 2008;

10(3): 435-438.

Leonard ST, Droege M. The uses and benefits of cluster analysis in pharmacy

research. Research in Social Administrative Pharmacy, 2008; 4 (1): 1-11.

Li W, Yi S, Wang Z, Chen S, Xin S, Xie J, Zhao C. Self-nanoemulsifying drug

delivery system of persimmon leaf extract: Optimization and bioavailability studies.


Li W, Yang Y, Tian Y, Xu X, Chen Y, Mu L, Zhang Y, Fang L. Preparation and in-

vitro/in-vivo evaluation of revaprazan hydrochloride nanosuspension. International

Journal of Pharmaceutics, 2011a; 408 (1-2): 157-162.

Li X, Gu L, Xu Y, Wang Y. Preparation of fenofibrate nanosuspension and study of

its pharmacokinetic behavior in rats. Drug Development and Industrial

Pharmacy, 2009; 35 (7): 827-833.

Lindmark T, Nikkila T, Artursson P. Mechanism of absorption enhancement by

medium chain fatty acids in intestinal epithelial Caco-2 monolayers. The Journal of

Pharmacology and Experimental Therapeutics, 1995; 275: 958-964.




Lionberger RA, Lee SL, Lee L, Raw A, Yu LX. Quality by Design: Concepts for

ANDAs. The AAPS Journal, 2008; 10 (2): 268-276.

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational

approaches to estimate solubility and permeability in drug discovery and development

settings. Advance Drug Delivery Reviews, 2001; 46: 3-26.

Liu H, Shang K, Liu W, Leng D, Li R, Kong Y, Zhang T. Improved oral

bioavailability of glyburide by a self-nanoemulsifying drug delivery system. Journal

of Microencapsulation, 2014; 31(3): 277-283.

Liu P, Rong X, Laru J, van Veen B, Kiesvaara J, Hirvonen J, Laaksonen T, Peltonen

L. Nanosuspensions of poorly soluble drugs: preparation and development by wet

milling. International Journal of Pharmaceutics, 2011; 411: 215-222.

Liversidge GG, Cundy KC, Bishop J. Surface modified drug nanoparticles. US Patent

5,145,684; 1992.

Liversidge GG, Cundy KC. Particle size reduction for improvement of oral

bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of

nanocrystalline danazol in beagle dogs. International Journal of Pharmaceutics,

1995; 125: 91-97.

Loh ZH, Samanta AK, Heng PWS. Overview of milling techniques for improving the

solubility of poorly water-soluble drugs. Asian Journal of Pharmaceutical Sciences,

2015; 10: 255-274.

Mahmoud EA, Bendas ER, Mohamed MI. Preparation and evaluation of self-

nanoemulsifying tablets of carvedilol. AAPS PharmSciTech, 2009; 10 (1): 183-192.

Manach C, Scalbert A, Morand C, Re´me´sy C, Jime´nez L. Polyphenols: food

sources and bioavailability. The American Journal of Clinical Nutrition, 2004; 79:

727-747.

Mariajancyrani J, Chandramohan G, Ravikumar R. Isolation and identification of

phytoconstituents from Delonic Regia Leaves. International Journal of Pharmacy and

Pharmaceutical Sciences, 2013; 5(4): 671-674.




Martin A. Physical Pharmacy, 4th ed. Philadelphia. Lippincott Williams & Wilkins;

1993.

Massart DL, Heyden YV. From Tables to Visuals: Principal Component Analysis,

Part 2. LC-GC Europe, 2005; 18 (2): 84-89.

Matteucci ME, Brettmann BK, Rogers TL, Elder EJ, Williams RO 3rd, Johnston KP.

Design of potent amorphous drug nanoparticles for rapid generation of highly

supersaturated media. Molecular Pharmaceutics, 2007; 4(5): 782-793.

Mauludin R, Müller RH, Keck CM. Development of an oral rutin nanocrystal

formulation. International Journal of Pharmaceutics, 2009; 370: 202-209.

Maurya DP, Sultana Y, Aqil M, Panda BP, Ali A. Formulation and optimization of

alkaline extracted ispaghula husk microscopic reservoirs of isoniazid by box-behnken

statistical design. Journal of Dispersion Science and Technology, 2011; 32: 424-432.

Mennini N, Furlanetto S, Cirri M, Mura P. Quality by design approach for developing

chitosan Ca-alginate microspheres for colon delivery of celecoxib hydroxpropyl β-

cyclodextrin PVP complex. European Journal of Pharmaceutics and

Biopharmaceutics, 2012; 80: 67-75.

Mennini N, Furlanetto S, Maestrelli F, Pinzauti S, Mura P. Response surface

methodology in the optimization of chitosan–Ca pectinate bead formulations.

European Journal of Pharmaceutical Sciences, 2008; 35: 318-325.

Merisko-Liversidge E, Liversidge GG. Nanosizing for oral and parenteral drug

delivery: a perspective on formulating poorly-water soluble compounds using wet

media milling technology. Advanced Drug Delivery Reviews, 2011; 63(6): 427-440.

Mezghrani O, Ke X, Bourkaib N, Xu BH. Optimized self-microemulsifying drug

delivery systems (SMEDDS) for enhanced oral bioavailability of astibilin. Pharmazie,

2011; 66: 754-760.

Mohd AB, Sanka K, Bandi S, Diwan PV, Shastri N. Solid self-nanoemulsifying drug

delivery system (S-SNEDDS) for oral delivery of glimepiride: development and

antidiabetic activity in albino rabbits. Drug Delivery, 2015; 22 (4): 499-508.




Monteiro A, Afolabi A, Bilgili E. Continuous production of drug nanoparticle

suspensions via wet stirred media milling: a fresh look at the Rehbinder effect. Drug


Mosharraf C, Nystrom C. The effect of particle size and shape on the surface specific

dissolution rate of micronized practically insoluble drugs. International Journal of

Pharmaceutics, 1995; 122: 35-47.

Mukherjee T, Plakogiannis FM. Development and oral bioavailability assessment of a

supersaturated self-microemulsifying drug delivery system (SMEDDS) of

albendazole. Journal of Pharmacy and Pharmacology, 2010; 62 (9): 1112-1120.

Muller RH, Jacobs C. Production and characterization of a budenoside

nanosuspesnion for pulmonary administration. Pharmaceutical Research, 2002; 19:

189-194.

Muller RH, Moschwitzer J, Bushrab FN. Manufacturing of nanoparticles by milling

and homogenisation techniques, In: Gupta RB, Kompella UB (ed.), Nanoparticle

Technology for Drug Delivery, Taylor and Francis Group, New York; 2006: 21-52.

Müller RH, Gohla S, Keck CM. State of the art of nanocrystals--special features,

production, nanotoxicology aspects and intracellular delivery. European Journal of

Pharmaceutics and Biopharmaceutics, 2011; 78(1): 1-9.

Müller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in

therapy. Rationale for development and what we can expect for the future. Advanced

Drug Delivery Reviews, 2001; 47 (1): 3-19.

Naik SR, Niture NT, Ansari AA, Shah PD. Anti diabetic activity of embelin:

Involvement of cellular inflammatory mediators, oxidative stress and other markers.

Phytomedicine, 2013; 20 (10): 797-204.

Nakarani M, Misra AK, Patel JK, Vaghani SS. Itraconazole nanosuspension for oral

delivery: Formulation, characterization and in-vitro comparison with marketed

formulation. Daru Journal of Faculty of Pharmacy, 2010; 18 (2): 84-90.




Nanjwade BK, Patel DJ, Udhani RA, Manvi FV. Functions of lipids for enhancement

of oral bioavailability of poorly water soluble drugs. Scientia Pharmaceutica, 2011;

79(4): 705-727.

Naveen C, Shastri N, Tadikonda RR. Use of the liquisolid compact technique for

improvement of the dissolution rate of valsartan. Acta Pharmaceutica Sinica B, 2012;

2 (5): 502-508.

Nazzal S, Zaghloul AA, Khan MA. Effect of extra granular microcrystalline cellulose

on compaction, surface roughness and in-vitro dissolution of a self nanoemulsified

solid dosage form of Ubiquinone. Pharmaceutical Technology, 2002; 26: 86-98.

Nazzal S, Khan MA. Controlled release of a self-emulsifying formulation from a

tablet dosage form: stability assessment and optimization of some processing

parameters. International Journal of Pharmaceutics, 2006; 315 (1-2): 110-121.

Nekkanti V, Karatgi P, Prabhu R, Pillai R. Solid self-microemulsifying formulation

for candesartan cilexetil. AAPS PharmSciTech, 2010; 11 (1): 9-17.

Nekkanti V, Pillai R, Venkateshwarlu V, Harisudhan T. Development and

characterization of solid oral dosage form incorporating candesartan nanoparticles.

Pharmaceutical Development and Technology, 2009; 14 (3): 290-298.

Nepal PR, Han HK, Choi HK. Preparation and in-vitro-in-vivo evaluation of

Witepsol® H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of

coenzyme Q10. European Journal of Pharmaceutical Sciences, 2010; 39: 224-232.

Neusilin US2, Product Information Sheet, Gangwal Chemicals Ltd, India, 2013.

Newton JM, Pinto MR, Podczeck F. The preparation of pellets containing a surfactant

or a mixture of mono- and di-gylcerides by extrusion/spheronization. European

Journal of Pharmaceutical Sciences, 2007; 30(3-4): 333-342.

Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP, Wang R, Fang

X, Guo R, Zhang M, Lippman ME, Yang D, Wang S. Discovery of embelin as a cell-

permeable, small-molecular weight inhibitor of XIAP through structure-based




computational screening of a traditional herbal medicine three-dimensional structure

database. Journal of Medicinal Chemistry, 2004; 47(10): 2430-2440.

Niwa T, Miura S, Danjo K. Universal wet-milling technique to prepare oral

nanosuspension focused on discovery and preclinical animal studies - Development of

particle design method. International Journal of Pharmaceutics, 2011; 405 (1-2):

218-227.

Noyes A, Whitney W. The rate of solution of solid substances in their own solutions.

Journal of American Chemical Society, 1987; 19: 930-934.

Obitte NC, Ofokansi KC, Nzekwe IF, Esimone CO, Okoye IE. Self-Nanoemulsfiying

drug delivery systems based on melon oil and its admixture with a homolipid from

Bos Indicus for the delivery of Indomethacin. Tropical Journal of Pharmaceutical

Research, 2011; 10: 299-307.

Owen MR, Armitage M, Chatfield M, Davies B, Emiabata-Smith D, Freeman Hayes

D, Mann J, Ramsay T, Smith L, Squires B. A scientist’s viewpoint on promoting

effective use of experimental design: Then things a scientist wants to know about

experimental design. Pharmaceutical Statistics, 2003; 2: 15-29.

Paceol, Product Information Sheet, Gattefosse Pvt Ltd, India, 2013.

Pandya VM, Patel JK, Patel DJ. Formulation and optimization of nanosuspensions for

enhancing simvastatin dissolution using central composite design. Dissolution

Technologies, 2011; 18 (3): 40-45.

Parmar N, Singla N, Amin S, Kohli K. Study of cosurfactant effect on

nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self

nanoemulsifying drug delivery system. Colloids Surfaces B: Biointerfaces, 2011; 86

(2): 327-338.

Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S. Oil based nanocarrier

for improved oral delivery of silymarin: In-vitro and in-vivo studies. International

Journal of Pharmaceutics, 2011; 413 (1-2): 245-253.




Patel A, Shelat P, Lalwani A. Development and optimization of solid self-

nanoemulsifying drug delivery system (S-SNEDDS) using Scheffe’s design for

improvement of oral bioavailability of nelfinavir mesylate. Drug Delivery and

Translational Research, 2014; 4: 171-186.

Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by self-

microemulsifying drug delivery systems (SMEDDS). Drug Development and

Industrial Pharmacy, 2007; 33: 1318-1326.

Patel GV, Patel VB, Pathak A, Rajput SJ. Nanosuspension of efavirenz for improved

oral bioavailability: formulation optimization, in-vitro, in situ and in-vivo evaluation.

Drug Development and Industrial Pharmacy, 2013; 40 (1): 80-91.

Patel J, Dhingani A, Garala K, Raval M, Sheth N. Design and development of solid

nanoparticulate dosage forms of telmisartan for bioavailability enhancement by

integration of experimental design and principal component analysis. Powder

Technology, 2014a; 258: 331-343.

Patel M, Patel N, Patel R, et al. Formulation and evaluation of self-emulsifying drug

delivery system of lovastatin. Asian Journal of Pharmaceutical Sciences, 2010; 5:

266-275.

Patel RB, Patel MR, Bhatt KK, Patel BG. Formulation and characterization of

microemulsion drug delivery system for trasnasal administration of carbamazepine.

Bulletin of Faculty of Pharmacy, Cairo University, 2013a; 51 (2): 243-253.

Patel RK, Pundarikakshudu K, Momin M, Patel MM. Studies on formulation and in-

vitro dissolution of embelin tablets. Indian Journal of Pharmaceutical Sciences, 2006;

68 (2): 227-230.

Patel T, Patel LD, Suhagia BN, Soni T, Patel T. Formulation of Fenofibrate Liquisolid

Tablets Using Central Composite Design. Current Drug Delivery, 2014b; 11: 11-23.

Pathan R, Bhandari U. Preparation and characterization of embelin-phospholipid

complex as effective drug delivery tool. Journal of Inclusion Phenomena and

Macrocyclic Chemistry, 2011; 69: 139-147.




Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery

strategy. Journal of Pharmacy and Pharmacology, 2004; 56: 827-840.

Pavia DL. Introduction to Spectroscopy. Cengage Learning, 2009.

Poloxamer 188, Product Information Sheet, Torrent Pharmaceuticals ltd, India, 2013

Poloxamer 407, Product Information Sheet, Torrent Pharmaceuticals ltd, India, 2013

Poojari R. Embelin - a drug of antiquity: shifting the paradigm towards modern

medicine. Expert Opinion on Investigational Drugs, 2014; 23(3): 427-444.

Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug

solubilisation using lipid-based delivery systems. Advanced Drug Delivery Reviews,

2008; 60 (6): 673-691.

Porter CJ, Charman WN. In-vitro assessment of oral lipid based formulations.

Advanced Drug Delivery Reviews, 2001; 50: S127–S147.

Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral

administration: materials, methods and strategies. Advanced Drug Delivery Reviews,

2008; 60 (6): 625-637.

Pouton CW. Formulation of poorly water-soluble drugs for oral administration:

physicochemical and physiological issues and the lipid formulation classification

system. European Journal of Pharmaceutical Sciences, 2006; 29: 278-287.

Pouton CW. Lipid formulations for oral administration of drugs non emulsifying, self

emulsifying and ‘self-microemulsifying’ drug delivery systems. European Journal of

Pharmaceutics, 2000; 11 (2): 93-98.

Prajapati ST, Bulchandani HH, Patel DM, Dumaniya SK, Patel CN. Formulation and

Evaluation of Liquisolid Compacts for Olmesartan Medoxomil. Journal of Drug

Delivery, 2013; Article ID 870579: 1-9.

Pu X, Sun J, Wang Y, Wang Y, Liu X, Zhang P, Tang X, Pan W, Han J, He Z.

Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.

International Journal of Pharmaceutics, 2009; 379 (1): 167-173.




Pund S, Shete Y, Jagadale S. Multivariate analysis of physicochemical characteristics

of lipid based nanoemulsifying cilostazol—Quality by design. Colloids and Surfaces

B: Biointerfaces, 2014; 115: 29-36.

Rabinow BE. Nanosuspensions in drug delivery. Nature Reviews. Drug

Discovery, 2004; 3(9): 785-796.

Radfar M, Sudarshana MS, Kavitha HU, Satish S, Niranjan MH. Evaluation of

antibacterial and antifungal activity of root and root callus extracts of Trianthema

decandra L. African Journal of Biotechnology, 2012; 11(2): 510-515.

Ragonese R, Macka M, Hughes J, Petocz P. The use of the Box-Behnken

experimental design in the optimisation and robustness testing of a capillary

electrophoresis method for the analysis of ethambutol hydrochloride in a

pharmaceutical formulation. Journal of Pharmaceutical and Biomedical Analysis,

2002; 27 (6): 995-1007.

Rajalahti T, Kvalheim OM. Multivariate data analysis in pharmaceutics: A tutorial

review. International Journal of Pharmaceutics, 2011; 417: 280-290.

Rang MJ, Miller CA. Spontaneous emulsification of oils containing hydrocarbon,

nonionic surfactant, and oleyl alcohol. Journal of Colloid and Interface Science,

1999; 209(1): 179-92.

Rao YM, Kumar MP, Apte S. Formulations of nanosuspensions of albendazole for

oral administration. Current Nanoscience, 2008; 4: 53-58.

Rasenack N, Hartenhauer H, Müller BW. Microcrystals for dissolution rate

enhancement of poorly water-soluble drugs. International Journal of Pharmaceutics,

2003; 254: 137-145.

Ravinchandra R. Studies on dissolution behaviour of nanoparticulate curcumin

formulation. Advances in Nanoparticles, 2013; 2: 51-59.

Reiss H. Entropy-induced dispersion of bulk liquids. Journal of Colloid and Interface

Science, 1975; 53(1): 61-70.




Ringner M. What is principal component analysis? Nature Biotechnology, 2008; 26

(3): 303-304.

Rizwan M, Aqil M, Azeem A, Talegaonkar S, Sultana Y, Ali A. Enhanced

transdermal delivery of carvedilol using nanoemulsion as a vehicle. Journal of

Experimental Nanoscience, 2010; 5 (5): 390-411.

Roopwani R, Buckner IS. Understanding deformation mechanisms during powder

compaction using principal component analysis of compression data. International


Rowe RC, Sheskey PJ, Quinn ME (eds). Handbook of Pharmaceutical Excipients, 6th

ed. Pharmaceutical Press, Great Britain, 2009.

Saeedi M, Akbari J, Morteza-Semnani K, Enayati-Fard R, Sar-Reshteh-dar S,

Soleymani A. Enhancement of dissolution rate of indomethacin using liquisolid

compacts. Iranian Journal of Pharmaceutical Research, 2011; 10 (1): 25-34.

Sahoo NG, Kakran M, Shaal LA, Li L, Müller RH, Pal M, Tan LP. Preparation and

characterization of quercetin nanocrystals. Journal of Pharmaceutical Science, 2011;

100 (6): 2379-2390.

Salazar J, Ghanem A, Müller RH, Möschwitzer JP. Nanocrystals: comparison of the

size reduction effectiveness of a novel combinative method with conventional top-

down approaches. European Journal of Pharmaceutics and Biopharmaceutics, 2012;

81 (1): 82-90.

Salazar J, Heinzerling O, Müller RH, Möschwitzer JP. Process optimization of a

novel production method for nanosuspensions using design of experiments (DoE).


Sander C, Holm P. Porous magnesium aluminometasilicate tablets as carrier of a

cyclosporine self-emulsifying formulation. AAPS PharmSciTech, 2009; 10 (4): 1388-

1395.




Sanka K, Bandari S, Jukanti R, Veerareddy PR. Colon-Specific Microparticles of

Piroxicam: Formulation and Optimization Using 32 Factorial Design. Journal of

Dispersion Science and Technology, 2011; 32(10): 1396-1403.

Sanka K, Poienti S, Bari A, Diwan PV. Improved oral delivery of clonazepam

through liquisolid powder compact formulations: In-vitro and ex-vivo

characterization. Powder Technology, 2014; 256: 336-344.

Sayyad FJ, Tulsankar SL, Kolap UB. Design and development of liquisolid compact

of candesartan cilexetil to enhance dissolution. Journal of Pharmacy Research, 2013;

7 (5): 381-388.

Seo YG, Kim DW, Yousaf AM, Park JH, Chang P, Baek HH, Lim S, Kim JO, Yong

CS, Choi H. Solid self-nanoemulsifying drug delivery system (SNEDDS) for

enhanced oral bioavailability of poorly water-soluble tacrolimus: physicochemical

characterisation and pharmacokinetics. Journal of Microencapsulation, 2015; 32 (5):

503-510.

Serajuddin ATM. Salt formation to improve drug solubility. Advanced Drug Delivery

Reviews, 2007; 59: 603-616.

Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and

bioavilability assessment of ramipril nanoemulsion formulation. European Journal of


Shah JC, Chen JR, Chow D. Metastable Polymorph of Etoposide with Higher

Dissolution Rate. Drug Development and Industrial Pharmacy, 1999; 25 (1): 63-67.

Shah SR, Parikh RH, Chavda JR, Sheth NR. Glibenclamide Nanocrystals for

Bioavailability Enhancement: Formulation Design, Process Optimization, and

Pharmacodynamic Evaluation. Journal of Pharmaceutical Innovation, 2014; 9 (3):

227-237.

Shah TJ, Amin AF, Parikh JR, Parikh RH. Process optimization and characterization

of poloxamer solid dispersion of a poorly water-soluble drug. AAPS PharmSciTech,

2007; 8 (2): E1-E7.




Shahiwala A. Formulation approaches in enhancement of patient compliance to oral

drug therapy. Expert Opinion on Drug Delivery, 2011; 8(11): 1521-1529.

Shakeel F, Haq N, El-Badry M, Alanazi FK, Alsarra IA. Ultra fine super self-

nanoemulsifying drug delivery system (SNEDDS) enhanced solubility and dissolution

of indomethacin. Journal of Molecular Liquids, 2013; 180: 89-94.

Shanmugam S, Baskaran R, Balakrishnan P, Thapa P, Yong CS, Yoo BK. Solid self-

nanoemulsifying drug delivery system (S-SNEDDS) containing phophatidylcholine

for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein. European

Journal of Pharmaceutics and Biopharmaceutics, 2011; 79 (2): 250-257.

Sharma A, Shanker C, Tyagi LK, Singh M, Rao CV. Herbal medicine for market

potential in India: An overview. Academic Journal of Plant Sciences, 2008; 1(2): 26-

36.

Sharma DK, Joshi SB. Solubility enhancement strategies for poorly water soluble

drugs in solid dispersions: A review. Asian Journal of Pharmaceutical Sciences,

2007; 1 (1): 9-19.

Sharma P, Zujovic ZD, Bowmaker GA, Marshall AJ, Denny WA, Garg S. Evaluation

of a crystalline nanosuspension: polymorphism, process induced transformation and

in-vivo studies. International Journal of Pharmaceutics, 2011; 408 (1-2): 138-151.

Shrivastava A, Kapadia U. Design, optimization, preparation and evaluation of

dispersion granules of valsartan and formulation into tablets. Current Drug Delivery,

2009; 6: 28-37.

Sigfridsson K, Lundqvist A, Strimfors M. Co-administration of a nanosuspension of a

poorly soluble basic compound and a solution of a proton pump inhibitor--the

importance of gastrointestinal pH and solubility for the in-vivo exposure. Drug


Sigfridsson K, Nordmark A, Theilig S, Lindahl A. A formulation comparison between

micro- and nanosuspensions: the importance of particle size for absorption of a model




compound, following repeated oral administration to rats during early development.

Drug Development and Industrial Pharmacy, 2011a; 37 (2): 185-192.

Sikarwar MS, Sharma S, Jain AK, Parial SD. Preparation, characterization and

evaluation of marsupsin–phospholipid complex. AAPS PharmSciTech, 2008; 9: 129-

137.

Singare DS, Marella S, Gowthamrajan K, Kulkarni GT, Vooturi R, Rao PS.

Optimization of formulation and process variable of nanosuspension: An industrial

perspective. International Journal of Pharmaceutics, 2010; 402 (1-2): 213-220.

Singh AK, Chaurasiya A, Singh M, Upadhyay SC, Mukherjee R, Khar RK.

Exemestane loaded self-microemulsifying drug delivery system (SMEDDS)

development and optimization. AAPS PharmSciTech, 2008: 9 (2): 628-634.

Singh B, Dahiya M, Saharan V, Ahuja N. Optimizing drug delivery systems using

systematic ‘design of experiments’. Part II: retrospect and prospects. Critical Review

in Therapeutic Drug Carrier System, 2005a; 22 (3): 215-294.

Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic

“design of experiments.” Part I: Fundamental aspects. Critical Review in Therapeutic

Drug Carrier System, 2005; 22 (1): 27-105.

Singh B, Khurana L, Bandyopadhyay S, Kapil R, Katare OO. Development of

optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with

enhanced bioavailability potential. Drug Delivery, 2011; 18 (8): 599-612.

Singh SK, Ranjan P, Verma PRP, Razdan B. Glibenclamide-loaded self-

nanoemulsifying drug delivery system: development and characterization. Drug


Singh SK, Srinivasan KK, Gowthamarajan K, Singare DS, Prakash D, Gaikwad NB.

Investigation of preparation parameters of nanosuspension by top-down media milling

to improve thedissolution of poorly water-soluble glyburide. European Journal of

Pharmaceutics and Biopharmaceutics, 2011a; 78 (3): 441-446.




Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in

the strategies for disease prevention. African Journal of Traditional, Complementary

and Alternative Medicines, 2013; 10(5): 210-229.

Solutol® HS-15, Product Information Sheet, Signet, India, 2014.

Sonnergaard JM. Quantification of the compactibility of pharmaceuticals powders.

European Journal of Pharmaceutics and Biopharmaceutics, 2006; 62: 270-277.

Spireas S, Bolton M, Sanford M. Liquisolid Systems and Methods of Preparing Same.

U.S. Patent, 1999: US 5968550 A.

Spireas S, Bolton SM. Liquisolid systems and methods of preparing same. Europe

Patent, 2010: EP Patent 0946154 B1.

Spireas S. Liquisolid Systems and Methods of Preparing Same. U.S. Patent, 2002: US

6423339 B1.

Strickley RG. Currently marketed oral lipid based dosage forms: drug products and

excipients. In: Haus DJ (eds), Oral lipid-based formulations, enhancing the

bioavailability of poorly water soluble drugs. Informal Healthcare, Inc., New York,

2007: 1.31.

Sugimoto S, Niwa T, Nakanish Y, Danjo K. Novel ultra-cryo milling and co-grinding

technique in liquid nitrogen to produce dissolution-enhanced nanoparticles for poorly

water-soluble drugs. Chemical and Pharmaceutical Bulletin, 2012; 60 (3): 325-333.

Sun B, Yeo Y. Nanocrystals for the parenteral delivery of poorly water-soluble drugs.

Current Opinion in Solid State & Materials Science, 2012; 16 (6): 295-301.

Sun C, Grant DJW. Effects of initial particle size on the tableting properties of l-

lysine monohydrochloride dehydrate powder. International Journal of

Pharmaceutics, 2001; 215: 221-228.

Sun W, Mao S, Shi Y, Li LC, Fang L. Nanonization of itraconazole by high pressure

homogenization: stabilizer optimization and effect of particle size on oral absorption.

Journal of Pharmaceutical Sciences, 2011; 100 (8): 3365-3373.




Sun W, Ni R, Zhang X, Li LC, Mao S. Spray drying of a poorly water-soluble drug

nanosuspension for tablet preparation: formulation and process optimization with

bioavailability evaluation. Drug Development and Industrial Pharmacy, 2015; 41 (6):

927-933.

Syed IA, Pavani E. The liquisolid technique: Based drug delivery system.

International Journal of Pharmaceutical Sciences and Drug Research, 2012; 4 (2):

88-96.

Tao Y, Jiangling W, Huibi X, Xiangliang Y. A new solid self-microemulsifying

formulation prepared by spray-drying to improve the oral bioavailability of poorly

water soluble drugs. European Journal of Pharmaceutics and Biopharmaceutics,

2008; 70: 439-444.

Tarr BD, Yalkowsky SH. Enhanced intestinal absorption of cyclosporine in rats

through the reduction of emulsion droplet size. Pharmaceutical Research, 1989; 6:

40-43.

Tayel SA, Soliman II, Louis D. Improvement of dissolution properties of

Carbamazepine through application of the liquisolid tablet technique. European

Journal of Pharmaceutics and Biopharmaceutics, 2008; 69: 342-347.

Teeranachaideekul V, Junyaprasert VB, Souto EB, Müller RH. Development of

ascorbyl palmitate nanocrystals applying the nanosuspension technology.


Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen.

European Journal of Pharmaceutics and Biopharmaceutics, 2009; 73: 373-384.

Transcutol P, Product Information Sheet, BASF, India, 2013.

Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh

D, Löbenberg R. Physicochemical characterization of solid dispersions of

indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100.

Drug Development and Industrial Pharmacy, 2004; 30(3): 303-317.




Van Citters GW, Lin HC. The Ileal Brake: A Fifteen-year Progress Report. Current

Gastroenterology Reports, 1999; 1(5): 404-409.

Van Eerdenbrugh B, Vermant J, Martens JA, Froyen L, Van Humbeeck J, Augustijns

P, Van den Mooter G. A screening study of surface stabilization during the production

of drug nanocrystals. Journal of Pharmaceutical Sciences, 2009; 98 (6): 2091-2103.

Vasconcelos T, Sarmento B, Costa P. Solid dispersion as strategy to improve oral

bioavailability of poor water soluble drugs. Drug Discovery Today, 2007; 12: 1068-

1075.

Vaskula S, Vemula S, Bontha V, Garepally P. Liquisolid compacts: An approach to

enhance the dissolution rate of Nimesulide. Journal of Applied Pharmaceutical

Science, 2012; 2: 115-121.

Venkatesh G, Majid MI, Mansor SM, Nair NK, Croft SL, Navaratnam V. In-vitro

and in-vivo evaluation of self-microemulsifying drug delivery system of

buparvaquone. Drug Development and Industrial Pharmacy, 2010; 36 (6): 735-745.

Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions:

investigation of the role of stabilizers on Ostwald ripening. International Journal of

Pharmaceutics, 2011; 406(1-2): 145-152.

Villar AM, Naveros BC, Campmany AC, Trenchs MA, Rocabert CB, Bellowa LH.

Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS)

for enhanced dissolution of gemfibrozil. International Journal of Pharmaceutics,

2012; 431 (1-2): 161-175.

Wang L, Dong J, Chen J, Eastoe J, Li X. Design and optimization of a new self-

nanoemulsifying drug delivery system. Journal of Colloid and Interface Science,

2009; 330: 443-448.

Wang L, Hao Y, Liu N, Ma M, Yin Z, Zhang X. Enhance the dissolution rate and oral

bioavailability of pranlukast by preparing nanosuspensions with high-pressure

homogenizing method. Drug Development and Industrial Pharmacy, 2012; 38 (11):

1381-1389.




Wang P, Luo Q, Miao Y, Ying L, He H, Cai C, Tang X. Improved dissolution rate

and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering. Drug

Development and Industrial Pharmacy, 2012a; 38 (11):1344-1353.

Wang Y, Liu Z, Zhang D, Gao X, Zhang X, Duan C, Jia L, Feng F, Huang Y, Shen

Y, Zhang Q. Development and in-vitro evaluation of deacety mycoepoxydiene

nanosuspension. Colloids and Surfaces B, Biointerfaces, 2011; 83 (2): 189-197.

Wei Y, Ye X, Shang X, Peng X, Bao Q, Liu M, Guo M, Li F. Enhanced oral

bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system

(S-SEDDS). Colloids and Surfaces A: Physicochemical and.Engineering Aspects,

2012; 396: 22-28.

Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles.

Advanced Drug Delivery Reviews, 2011; 63: 456-469.

Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, Wang YT, Tong HH, Zheng

Y. Formulation development and bioavailability evaluation of a self-nanoemulsified

drug delivery system of oleanolic acid. AAPS PharmSciTech, 2009; 10 (1): 172-182.

Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, Cui F. Preparation of stable

nitrendipine nanosuspensions using the precipitation-ultrasonication method for

enhancement of dissolution and oral bioavailability. European Journal of

Pharmaceutical Sciences, 2010; 40 (4): 325-334.

Xuemei W, Jianhua X, Xiuwang H, Caixia W. Self-microemulsifying drug delivery

system improves curcumin dissolution and bioavailability. Drug Development and

Industrial Pharmacy, 2011; 37 (1): 15-23.

Yeom DW, Song YS, Kim SR, Lee SG, Kang MH, Lee S, Choi YW. Development

and optimization of a self-microemulsifying drug delivery system for atorvastatin

calcium by using D-optimal mixture design. International Journal of Nanomedicine,

2015; 10: 3865-3878.

Yoo JH, Shanmugam S, Thapa P, Lee ES, Balakrishnan P, Baskaran R, Yoon

SK, Choi HG, Yong CS, Yoo BK, Han K. Novel self-nanoemulsifying drug delivery




system for enhanced solubility and dissolution of lutein. Archives of Pharmacal

Research, 2010; 33 (3): 417-26.

Yosra SRE, Magda AE, Ossama YA. Self-nanoemulsifying drug delivery systems of

tamoxifen citrate: Design and Optimization. International Journal of Pharmaceutics,

2009; 380: 133–141.

Zhang D, Tan T, Gao L, Zhao W, Wang P. Preparation of azithromycin

nanosuspensions by high pressure homogenization and its physicochemical

characteristics studies. Drug Development Industrial Pharmacy, 2007; 33(5): 569-

575.

Zhang L, Chai G, Zeng X, He H, Xu H, Tang X. Preparation of fenofibrate immediate

release tablets involving wet grinding for improved bioavailability. Drug


Zhang N, She D, Hu L, Liu H. Preparation and Evaluation of Daidzein Loaded Self-

Microemulsifying Drug Delivery System. Applied Mechanics and Materials, 2012;

140 (2): 200-205.

Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying

drug delivery system of oridonin. International Journal of Pharmaceutics, 2008; 355

(1-2): 269-276.

Zhao Y, Wang C, Chow AHL, Ren K, Gong T, Zhang Z, Zheng Y. Self-

nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary

essential oil: Formulation and bioavailability studies. International Journal of

Pharmaceutics, 2010; 383: 170–177.

Zhu M, Ghodsi A. Automatic dimensionality selection from the scree plot via the use

of profile likelihood. Computational Statistics & Data Analysis, 2006; 51: 918- 930.

Zhu S, Hong M, Liu C, Pei Y. Application of Box-Behnken design in understanding

the quality of genistein self-nanoemulsified drug delivery systems and optimizing its

formulation. Pharmaceutical Development and Technology, 2009; 14 (6): 642-649.

Chapter 7 Bibliography - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/125847... · Journal...

Documents

Transcript of Chapter 7 Bibliography - Shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/125847... · Journal...